The Effect of Rituximab on the Development of Anti-Donor Antibodies and Resolution of B Cell Infiltration in the Renal Allograft of Patients Undergoing Rejection

Trial Profile

The Effect of Rituximab on the Development of Anti-Donor Antibodies and Resolution of B Cell Infiltration in the Renal Allograft of Patients Undergoing Rejection

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Nov 2014

At a glance

  • Drugs Rituximab (Primary)
  • Indications Kidney-pancreas transplant rejection; Renal transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jul 2011 Actual end date Dec 2010 added as reported by ClinicalTrials.gov.
    • 06 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top